Related content

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

By Chim C.   Lie A.   Chan E.   Leung Y.   Cheung S.   Chan S.   Liang Raymond   Kwong Y.  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1019-1027

Springer Publishing Company

Access to resources Recommend Favorite

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

By Lee Sung   Suh Cheolwon   Kim Bong-Seog   Chung Jooseop   Joo Young-Don   Ryoo Hun-Mo   Do Young   Jin Jong-Youl   Kang Hye   Lee Gyeong-Won   Lee Moon   Shim Hyeok   Kim Kihyun   Yoon Sung-Soo   Bang Soo   Kim Ho   Lee Je-Jung   Park Jinny   Lee Dong   Lee Jae-Hoon  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 905-912

Springer Publishing Company

Access to resources Recommend Favorite

Rapid control of previously untreated multiple myeloma with bortezomib–lenalidomide–dexamethasone (BLD)

By Wang M.   Delasalle K.   Giralt S.   Alexanian R.  

Hematology, Vol. 15, Iss. 2, 2010-04 ,pp. : 70-73

Maney Publishing

Access to resources Recommend Favorite

Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma

By Wang M.   Giralt S.   Delasalle K.   Handy B.   Alexanian R.  

Hematology, Vol. 12, Iss. 3, 2007-06 ,pp. : 235-239

Maney Publishing

Access to resources Recommend Favorite

Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene

By Bruno M.E.C.   West R.B.   Schneeman T.A.   Bresnick E.H.   Kaetzel C.S.  

Molecular Immunology, Vol. 40, Iss. 10, 2004-01 ,pp. : 695-708

Elsevier

Access to resources Recommend Favorite